Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.

@article{Condemi2001ComparisonOT,
  title={Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.},
  author={John J. Condemi},
  journal={Clinical therapeutics},
  year={2001},
  volume={23 9},
  pages={1529-41}
}
BACKGROUND Beta2-adrenergic agonists are frequently used for the prevention and relief of bronchospasm in patients with reversible obstructive airway disease. Formoterol and salmeterol are long-acting beta2-agonists. In addition to its long duration of action, formoterol has been reported to have an onset of action similar to that of albuterol. OBJECTIVE This study compared the effects on lung function of regular twice-daily inhalation of formoterol or salmeterol in adults with moderate to… CONTINUE READING